Human Umbilical Cord Mesenchymal Stem Cells Injection

BIOLOGICAL3 trials

Sponsors

Beijing Tuohua Weiye Biotechnology Co., Ltd., Jiangsu Topcel-KH Pharmaceutical Co., Ltd., BOE Technology Group Co., Ltd.

Conditions

AISAcute Ischemic StrokeArteriovenous Fistula StenosisDecompensated Hepatitis B Cirrhosis

Phase 1

Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis

RecruitingNCT07413549

Beijing Tuohua Weiye Biotechnology Co., Ltd.Decompensated Hepatitis B Cirrhosis

Start: 2025-02-25End: 2027-12-31Target: 76Updated: 2026-02-17

Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis in Patients With End-Stage Diabetic Kidney Disease

Not yet recruitingNCT07452822

Jiangsu Topcel-KH Pharmaceutical Co., Ltd.Arteriovenous Fistula Stenosis

Start: 2026-02-20End: 2028-03-30Target: 54Updated: 2026-03-05

A Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells for Acute Ischemic Stroke

Not yet recruitingNCT07628933

BOE Technology Group Co., Ltd.Acute Ischemic Stroke, AIS

Start: 2026-06-30End: 2029-11-30Target: 35Updated: 2026-06-05